Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance.

Insulin and glucagon secretion was compared in women with impaired glucose tolerance (IGT; n = 19, age 58.4 +/- 0.3 yr; mean +/- SD) and women with normal glucose tolerance (NGT; n = 40, age 58.4 +/- 0.3 yr). Fasting plasma insulin levels were higher in IGT than in NGT (P = 0.026), whereas fasting glucose and glucagon levels were not different. Arginine was injected intravenously (5 g), which rapidly stimulated insulin and glucagon secretion in all subjects. Raising the blood glucose (BG) to 14 and 28 mmol/L potentiated insulin secretion and inhibited glucagon secretion. The acute insulin response to arginine (AIR = 2-5 min postload increase) at BG 14 mmol/L, but not at fasting BG or BG 28 mmol/L, was lower in IGT than in NGT (P = 0.033), as was the glucose potentiation of AIR (slopeAIR) (P = 0.020). The acute glucagon response (AGR) was higher in IGT than in NGT at BG 14 mmol/L (P = 0.016). SlopeAGR (glucose inhibition of AGR) was reduced in IGT (P = 0.001). In NGT, there was a significant inverse correlation between slopeAIR and slopeAGR (P = 0.002) not seen in IGT. We conclude that in IGT with normal fasting BG, the glucose modulation of islet function is impaired, indicating that islet dysfunction is an early lesion during the development of noninsulin-dependent diabetes mellitus.

[1]  P. Allhoff,et al.  Bogalusa Heart Study , 2020, Encyclopedia of Behavioral Medicine.

[2]  M. Rewers,et al.  Global Estimates for Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in Adults , 1993, Diabetes Care.

[3]  J. Halter,et al.  Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. , 1984, The Journal of clinical investigation.

[4]  E. Samols,et al.  Intra-islet regulation. , 1988, The American journal of medicine.

[5]  J. Halter,et al.  Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. , 1979, The Journal of clinical endocrinology and metabolism.

[6]  G. Reaven,et al.  Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? , 1976, The American journal of medicine.

[7]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[8]  P. Bennett,et al.  The natural history of impaired glucose tolerance in the Pima Indians. , 1988, The New England journal of medicine.

[9]  R. Sicree,et al.  Plasma Insulin Response Among Nauruans: Prediction of Deterioration in Glucose Tolerance Over 6 Yr , 1987, Diabetes.

[10]  C. Bengtsson,et al.  Fasting Serum Insulin Concentration and Early Insulin Response as Risk Determinants for Developing Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[11]  A. Vaag,et al.  A Simple Method for Quantitation of Insulin Sensitivity and Insulin Release from an Intravenous Glucose Tolerance Test , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[12]  Marija J. Norusis,et al.  SPSS for Windows Base System User''s Guide , 1992 .

[13]  E. Cerasi,et al.  Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects. , 1973, Lancet.

[14]  S. Lillioja,et al.  Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. , 1991, The Journal of clinical endocrinology and metabolism.

[15]  R Luft,et al.  The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. , 1967, Acta endocrinologica.

[16]  R. N. Bergman,et al.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study , 1992, The Lancet.

[17]  D. Johnston,et al.  Ethnic Differences in Insulin Secretion in Women at Risk of Future Diabetes , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[18]  R. Bergman,et al.  Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. , 1990, The Journal of clinical endocrinology and metabolism.

[19]  V. Grill Time and dose dependencies for priming effect of glucose on insulin secretion. , 1981, The American journal of physiology.

[20]  J. Cruickshank,et al.  Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure , 1991, The Lancet.

[21]  D. Porte β-cells in type II diabetes mellitus , 1991, Diabetes.

[22]  B V Howard,et al.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.

[23]  T. W. Haeften,et al.  Decreased insulin secretory capacity and normal pancreatic B‐cell glucose sensitivity in non‐obese patients with NIDDM , 1991, European journal of clinical investigation.

[24]  E. Cerasi Potentiation of insulin release by glucose in man. , 1975, Acta endocrinologica.

[25]  S. Bonner-Weir,et al.  Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes. , 1990, The Journal of clinical investigation.